https://www.live-feeds.com/feed/one-blood-test-could-screen-you-for-50-cancers-here-s-why-it-s-controversialContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/one-blood-test-could-screen-you-for-50-cancers-here-s-why-it-s-controversialhttps://www.live-feeds.com/feed/one-blood-test-could-screen-you-for-50-cancers-here-s-why-it-s-controversial#u86200Sun, 27 Sep 2026 12:21:33 +0000An advisory panel to the Food and Drug Administration has endorsed a controversial multi-cancer early detection blood test developed by Grail. The test aims to screen for more than 50 types of cancer from a single blood draw. While recent studies including the Pathfinder 2 trial and Mayo Clinic research have highlighted the test's ability to detect multiple cancer types, the screening tool remains a subject of ongoing debate among medical experts regarding its overall performance, safety, and clinical utility.Why it mattersMulti-cancer early detection tests represent a major shift in onco